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Background
Abnormal results of microsatellite instability (MSI) or
immunohistochemistry (IHC) testing of colorectal
(CRC) tumors may suggest the presence of Lynch Syn-
drome (LS), a hereditary cause of CRC. Individuals with
LS are at high risk for second primary cancers. Abnor-
mal results of MSI and IHC testing influence care deci-
sions. MSI is also a prognostic marker. The purpose of
this survey-based study is to determine the current MSI
and IHC testing practices and subsequent follow-up of
abnormal results in U.S. cancer programs. The study
aims include to: 1) explore the practice of MSI/IHC
testing based on type of cancer program and the num-
ber of CRC cases accessioned during 2009 and 2) identi-
fying the process and factors associated with follow-up
of abnormal results. Routine MSI and IHC testing of
C R Ct u m o r si sa ne m e r g i n gp r a c t i c ei nt h eU . S .T o
date, no published studies were found that describe the
practice of reflex testing for MSI and IHC abnormalities
on colorectal tumors in the U.S.
Methods and materials
A study packet (i.e., letter of invitation, survey, $5.00
incentive, and postage-paid return envelope) will be
mailed to the cancer program and tumor registry direc-
tors at the 40 NCI-designated Comprehensive Cancer
Centers, 567 ACS-accredited Community Hospital Com-
prehensive Cancer Programs, and 521 ACS-accredited
Community Hospital Cancer Programs in the U.S. Col-
laboration between the directors of the cancer program
and tumor registry will be encouraged and only one set
of survey responses per cancer program will be retained.
The survey was developed based on input from an inter-
nal and external panel of experts and revised following
pilot testing in 22 centers (99.5% return rate). The sur-
vey includes 11 check-box items of which 6 also have
an option to write in comments. Recruitment will follow
Dillman’s method (i.e. pre-notice letter; study packet,
thank you/reminder postcard; repeating up to 2 cycles).
Center characteristics and MSI/IHC practices will be
summarized using descriptive statistics. Chi square tests
will explore associations between type of cancer pro-
gram and MSI/IHC testing practices. Analysis of var-
iance or planned comparisons will examine differences
between program’sC R Cc a s e si n2 0 0 9a n dt h et y p eo f
cancer program. Content analysis will be used to analyze
narrative responses to survey questions.
Conclusions
The findings of this study may influence (and ultimately
enhance) uptake and translation of MSI and IHC testing
practices for newly diagnosed CRC tumors, which may
lead to improved cancer screening and prevention
practices.
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